Acute Myelogenous Leukemia

Filter By:
Filmed at the 2014 Great Debates and Updates in Hematologic Malignancies Congress in New York, this online activity is comprised of three videos wherein Dr. James M. Epstein is joined by Drs. Robert Z. Orlowski, David P. Steensma, and John P. Leonard to discuss recent clinical advances in hematologic malignancies. This engaging conversational forma...
by:imedex | 80 views
Download from iTunes: https://itun.... Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world's largest p...
by:mdanderson | 291 views
Antibody-drug conjugates or ADCs represent an innovative therapeutic application that combines the unique properties of monoclonal antibodies (mAbs) with the potent cell killing activity of cytotoxic small molecule drugs. The key components of antibody-drug conjugates include a monoclonal antibody (mAbs), a stable linkers and a cytotoxic (anti...
by:ADCReview | 919 views
Drs. Ravandi-Kashani, Czuczman, Steensma, Cortes, Anderson, and Brown comprise the faculty for this compelling group of interviews with Dr. Jim Epstein as moderator. These internationally known physicians interpret data presented at the 55th Annual American Society of Hematology (ASH) 2013 meeting in New Orleans and provide take home points for the...
by:imedex | 1305 views
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelod...
by:mdanderson | 2208 views
The University of Texas MD Anderson Cancer Center in September 2012 announced its Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. The program initially targets acute myelogenous leu...
by:mdanderson | 2226 views
Dr. Elihu Estey, Acute Myeloid Leukemia (AML) expert from the Seattle Cancer Care Alliance, shares results from a recent study reported at ASH 2012 offering hope for patients with Acute Promyelocytic Leukemia (APL), a distinct subtype of Acute Myeloid Leukemia (AML). As a lead investigator on many r...
by:patientpower | 1997 views
Dr. Rainer Storb, Head of the Transplantation Biology Program at the Fred Hutchinson Cancer Research Center, details important advances in tranplant for Acute Myeloid Leukemia (AML). He shares an update on the use of novel agents and their impact on remission and overall survival for patients, refinements in treatment for the elderly with AML and a...
by:patientpower | 1763 views
Around 15,000 people in the United States are diagnosed each year with myelodysplastic syndrome (MDS). MDS occurs when the bone marrow does not properly produce one or more of the following: red blood cells, white blood cells and/or platelets. In the past it was thought MDS was only deadly when it developed into acute myelogenous leukemia (AML), b...
by:mdanderson | 1620 views
Download from iTunes: http://bit.l.... Acute myeloid leukemia (AML) occurs when too many immature blood cells are produced by the bone marrow. Anemia, infection and bleeding may result and become life threatening. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson Cancer Center...
by:mdanderson | 1412 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)